Adjuvant therapy after surgery for breast cancer--should women without axillary node involvement be candidates
Dent, D.M.; Hacking, E.A.; Gudgeon, C.A.
South African Medical Journal 75(11): 513-514
1989
ISSN/ISBN: 0256-9574 PMID: 2727837 Document Number: 346121
Document emailed within 1 workday
Related Documents
Roumen, R.M. 2000: Prognostic benefits evaluated: new guidelines for systemic adjuvant therapy for axillary node-negative breast cancer vs. implementation of sentinel node biopsy procedure Nederlands Tijdschrift Voor Geneeskunde 144(21): 980-984Mathoulin-Portier, M.P.; Meynard, P.; Charton-Bain, M.C.; Escoute, M.; Bardou, V.J.; Puig, B.; Viens, P.; Cowen, D.; Houvenaeghel, G.; Hassoun, J.; Jacquemier, J. 1999: Peritumoral vascular invasion in women with node-negative breast cancer, receiving no adjuvant therapy Anticancer Research 19(1b): 843-847
Yamamoto, N.; Tabei, T.; Inoue, K.; Takei, H.; Sato, N.; Yanagita, Y.; Fujisawa, T.; Fujii, H.; Saeki, T.; Kurosumi, M. 2010: Tolerability and safety of docetaxel plus cyclophosphamide as adjuvant chemotherapy for axillary lymph node-negative breast cancer--JECBC04 trial Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(1): 57-63
Allen, B.; Campbell, I.; Desai, S.; Dray, M.; Scarlet, J. 2001: Pilot study comparing the accuracy of lymphoscintigraphy sentinel lymph node localisation with axillary node dissection in women with operable breast cancer New Zealand Medical Journal 114(1132): 233-236
Hudis, C.A.; Seidman, A.D.; Baselga, J.; Raptis, G.; Lebwohl, D.; Gilewski, T.; Currie, V.; Moynahan, M.E.; Sklarin, N.; Fennelly, D. 1995: Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes Seminars in Oncology 22(6 Suppl 15: 18-23
Sato, K.; Hiraide, H.; Mochizuki, H. 2001: Sentinel lymph node (SLN) in breast cancer: prediction of axillary metastasis confined to the SLN spares patients further axillary dissection Nihon Geka Gakkai Zasshi 102(6): 445-448
1990: Node-negative breast cancer: identifying those who should be spared adjuvant therapy Oncology 4(12): 15-16
Caldarola, L.; Calderini, P.; Volterrani, P.; Di Carlo, F.; Gaglia, P. 1983: The correlation between estrogen receptor status, axillary-node metastases and disease-free interval after surgery in primary breast cancer Italian Journal of Surgical Sciences 13(3): 179-185
Iwata, H.; Miura, S. 2002: Axillary lymph node dissection in clinically node-positive breast cancer Nihon Geka Gakkai Zasshi 103(11): 831-834
Avital, S.; Greenberg, R.; Cohen, M.; Stadler, J.; Skurnik, Y.; Schneebaum, S. 1998: Sentinel node biopsy in breast cancer--a new method for diagnosis of axillary lymph node metastasis Harefuah 134(10): 809-813
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Karalak, A.; Homcha-Em, P. 1999: Occult axillary lymph node metastases discovered by serial section in node-negative breast cancer Journal of the Medical Association of Thailand 82(10): 1017-1019
Saimura, M.; Mitsuyama, S.; Anan, K.; Tanaka, M.; Shimada, K.; Hirose, N.; Ogawa, S.; Tamaki, N.; Tomisaki, S.; Tamura, K. 2008: Adjuvant epirubicin and cyclophosphamide followed by weekly paclitaxel for Japanese women with node-positive breast cancer: a multi-institutional feasibility study Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(9): 1519-1523
Spigel, D.R.; Hainsworth, J.D.; Burris, H.A.; Molthrop, D.C.; Peacock, N.; Kommor, M.; Vazquez, E.R.; Greco, F.A.; Yardley, D.A. 2011: A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer Clinical Advances in Hematology and Oncology: H&o 9(4): 280-286
Singhal, H.; O'Malley, F.P.; Tweedie, E.; Stitt, L.; Tonkin, K.S. 1997: Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques Canadian Journal of Surgery. Journal Canadien de Chirurgie 40(5): 377-382
1990: Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group Lancet 335(8705): 1565-1568
Margolis, D.S.; McMillen, M.A.; Hashmi, H.; Wasson, D.W.; MacArthur, J.D. 1992: Aggressive axillary evaluation and adjuvant therapy for nonpalpable carcinoma of the breast Surgery Gynecology and Obstetrics 174(2): 109-113
Seretis, C.; Seretis, F. 2016: Development of a novel scoring system to potentially avoid completion axillary lymph node clearance after breast cancer excision and positive sentinel lymph node biopsy Journal of BUON: Official Journal of the Balkan Union of Oncology 21(5): 1316-1319
Zaman, K.; Ambrosetti, A.; Perey, L.; Jeanneret-Sozzi, W.; Delaloye, J.F.; De Ziegler, D. 2007: Breast cancer in young women: adjuvant therapy and fertility Revue Medicale Suisse 3(112): 1298-1300; 1302, 1304
Procaccini, E.; Ruggiero, R.; Mansi, L.; Laprovitera, A.P.; Rambaldi, P.F.; Cuccurullo, V.; Ferrara, A.; Procaccini, F.; Zenone, P. 2003: Modulation of the axillary lymph node dissection in breast cancer Annali Italiani di Chirurgia 74(1): 21-8; Discussion 28-9